Neurological soft signs are associated with APOE genotype, age and cognitive performance

Journal of Alzheimer's Disease

Volumn 7, Issue 4, 2005, Pages 325-330

  Lautenschlager, N T ^a   Wu, Jing Shan ^a,b   Laws, S M ^a,b   Almeida, O P ^a   Clarnette, R M ^a,b   Joesbury, K ^a,b   Wagenpfeil, S ^d   Martins, G ^a,b   Paton, A ^a,b   Gandy, S E ^b,c   Forstl H ^e   Martins, R N ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

apoE promoter polymorphisms; Apolipoprotein E; Cognitive decline; Memory impairment; Neurological soft signs

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGIC ASSESSMENT; SAMPLE SIZE;

EID: 23944446055     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-7409     Document Type: Article

References (21)

1. O. Almeida, R. Howard, R. Levy and A. David, Psychotic states arising in late life (late paraphrenia): the role of risk factors, Brit J Psychiatry 166 (1995), 215-228.
2. J. Breitner, J. Anthony, K. Welsh-Bohmer, D. Steffens, M. Norton, J. Tschanz, B. Plassman, M. Meyer, I. Skoog and A. Khachaturian, APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study, Neurology 53 (1999), 321-331.
3. M. Bullido, M. Artiga, M. Recuero, I. Sastre, M. Garcia, J. Aldudo, C. Lendon, S. Han, J. Morris, J. Vazquez, A. Goate and F. Valdivieso, A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia, Nature Genet 18 (1998), 69-71.
4. R. Clarnette, O. Almeida, H. Forstl, A. Paton and R. Martins, Clinical characteristics of individuals with subjective memory loss in Western Australia: results from a cross-sectional survey, Int J Geriatrs Psychiatry 16 (2001), 168-174.
5. M. Das, V. Kumari, W. Soni, U. Ettinger, B. Binneman, C. Hughes, R. Mehrotra and T. Sharma, Neurological soft signs and their relationship tp cognitive and clinical efficacy of atypical antipsychotics in schizophrenia, Schizophrenia Bulletin 30(2) (2004), 241-253.
6. L. Farrer, L. Cupples, J. Harris, B. Hyman, W. Kukull, R. Mayeux, R. Myers, M. Pericak-Vance, N. Risch and C. van Duijn, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium, JAMA 278 (1997), 1349-1356.
7. H. Förstl, A. Burns, R. Levy, N. Cairns, P. Luthert and P. Lantos, Neurologic signs in Alzheimer's disease: results of a prospective clinical and neuropathologic study, Arch Neurol 49 (1992), 1038-1042.
8. J. Hixson and D. Vermier, Restriction of human apolipoprotein E by gene amplification and cleavage with Hla1, J Lipid Res 31 (1990), 545-548.
9. C. Jonker, M. Geerlings and B. Schmand, Are memory complaints predictive for dementia? A review of clinical and population-based studies, Int J Geriatr Psychiatry 15 (2000), 983-991.
10. N. Lautenschlager, L. Cupples, V. Rao, S. Auerbach, R. Becker, J. Burke, H. Chui, R. Duara, E. Foley, S. Glatt, R. Green, R. Jones, H. Karlinsky, W. Kukull, A. Kurz, E. Larson, K. Martelli, A. Sadovnick, L. Volicer, S. Waring, J. Growdon and L. Farrer, Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46 (1996), 641-650.
11. S. Laws, E. Hone, K. Taddei, C. Harper, B. Dean, C. McLean, C. Masters, N. Lautenschlager, S. Gandy and R. Martins, Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E, Mol Psychiatry 7 (2002), 886-890.
12. S. Laws, R. Clarnette, K. Taddei, G. Martins, A. Paton, J. Hallmayer, O. Almeida, D. Groth, S. Gandy, H. Forstl and R. Martins, APOE-ε4 and -491A allele frequencies and apoE levels among non-demented subjects who complain of memory impairment: results from a cross-sectional analysis, Mol. Psychiatry 7(7) (2002), 768-775.
13. S. Laws, R. Clarnette, K. Taddei, G. Martins, A. Paton, O. Almeida, H. Forstl and R. Martins, Association between the presenilin-1 mutation GLU318GLY and complaints of memory impairment among non-demented subjects, Neurobiol Aging 23 (2002), 55-58.
14. R. Martins, R. Clarnette, C. Fisher, G. Broe, W. Brooks, P. Montgomery and S. Gandy, ApoE genotype in Australia: Roles in early and late onset Alzheimer's disease and Down's syndrome, NeuroReport 6 (1995), 1513-1516.
15. Y. Namba, H. Kawasaki, E. Otomo and K. Ikeda, Apolipoprotein E immunreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease, Brain Research 541 (1991), 163-166.
16. M. Roth, F. Huppert, C. Mountjoy and E. Tyme, CAMDEX-R. The Cambridge examination for mental disorders of the elderly - revised, Cambridge University Press, 1998.
17. W. Strittmatter, A. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. Salvesen and A. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease, Proc Natl Acad Sci 90 (1993), 1977-1981.
18. J. Verghese, R. Lipton, C. Hall, G. Kuslansky, M. Katz and H. Buschke, Abnormality of gait as a predictor of non-Alzheimer's dementia, N Engl J Med 22 (2002), 1761-1768.
19. A. Verkkoniemi, M. Somer, J. Rinne, L. Myllykangas, R. Crook, J. Hardy, M. Viitanen, H. Kalimo and M. Haltia, Variant Alzheimer's disease with spastic paraparesis. Clinical characterization, Neurology 54 (2000), 1103-1109.
20. L. Waite, G. Broe, H. Creasy, D. Grayson, B. Edelbroc and D. O'Toole, Neurological signs, aging, and the neurodegenerative syndromes, Arch Neurol 53 (2001), 498-502.
21. P. Wenham, W. Price and G. Blundell, Apolipoprotein E genotyping by one-stage PCR, Lancet 337 (1991), 1158-1159.